- Home
- AITR vs ONCY Comparison
AITR vs ONCY Comparison
Compare AITR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AITR
- ONCY
- Stock Information
- Founded
- AITR 2022
- ONCY 1998
- Country
- AITR United States
- ONCY Canada
- Employees
- AITR N/A
- ONCY N/A
- Industry
- AITR
- ONCY Pharmaceuticals and Biotechnology
- Sector
- AITR
- ONCY Health Care
- Exchange
- AITR Nasdaq
- ONCY Nasdaq
- Market Cap
- AITR 82.6M
- ONCY 103.8M
- IPO Year
- AITR 2023
- ONCY 1999
- Fundamental
- Price
- AITR $10.54
- ONCY $1.19
- Analyst Decision
- AITR
- ONCY Strong Buy
- Analyst Count
- AITR 0
- ONCY 2
- Target Price
- AITR N/A
- ONCY $4.00
- AVG Volume (30 Days)
- AITR 71.3K
- ONCY 903.7K
- Earning Date
- AITR 01-01-0001
- ONCY 11-05-2024
- Dividend Yield
- AITR N/A
- ONCY N/A
- EPS Growth
- AITR N/A
- ONCY N/A
- EPS
- AITR N/A
- ONCY N/A
- Revenue
- AITR N/A
- ONCY N/A
- Revenue This Year
- AITR N/A
- ONCY N/A
- Revenue Next Year
- AITR N/A
- ONCY N/A
- P/E Ratio
- AITR N/A
- ONCY N/A
- Revenue Growth
- AITR N/A
- ONCY N/A
- 52 Week Low
- AITR $10.11
- ONCY $0.84
- 52 Week High
- AITR $10.57
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- AITR 78.43
- ONCY 52.51
- Support Level
- AITR $10.51
- ONCY $1.17
- Resistance Level
- AITR $10.57
- ONCY $1.28
- Average True Range (ATR)
- AITR 0.01
- ONCY 0.09
- MACD
- AITR -0.00
- ONCY -0.01
- Stochastic Oscillator
- AITR 83.33
- ONCY 28.00
About AITR AI TRANSPORTATION ACQUISITION CORP Ordinary shares
AI Transportation Acquisition Corp is a blank check company.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.